Impedimed Limited Stock Price To Book
| IPDQF Stock | USD 0.06 0.02 26.69% |
ImpediMed Limited fundamentals help investors to digest information that contributes to ImpediMed's financial success or failures. It also enables traders to predict the movement of ImpediMed Pink Sheet. The fundamental analysis module provides a way to measure ImpediMed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ImpediMed pink sheet.
ImpediMed |
ImpediMed Limited Company Price To Book Analysis
ImpediMed's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current ImpediMed Price To Book | 2.74 X |
Most of ImpediMed's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ImpediMed Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, ImpediMed Limited has a Price To Book of 2.7392 times. This is 89.33% lower than that of the Healthcare sector and 51.69% lower than that of the Medical Devices industry. The price to book for all United States stocks is 71.2% higher than that of the company.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
ImpediMed Fundamentals
| Return On Equity | -0.52 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (1.88) % | |||
| Operating Margin | (2.00) % | |||
| Current Valuation | 81.27 M | |||
| Shares Outstanding | 1.79 B | |||
| Shares Owned By Insiders | 13.73 % | |||
| Shares Owned By Institutions | 14.96 % | |||
| Price To Earning | (8.46) X | |||
| Price To Book | 2.74 X | |||
| Price To Sales | 9.22 X | |||
| Revenue | 10.49 M | |||
| Gross Profit | 9.16 M | |||
| EBITDA | (18.77 M) | |||
| Net Income | (19.87 M) | |||
| Cash And Equivalents | 40.73 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 170 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 6.44 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (15.66 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 73 | |||
| Beta | 2.67 | |||
| Market Capitalization | 78.57 M | |||
| Total Asset | 58.7 M | |||
| Retained Earnings | (150 M) | |||
| Working Capital | 83 M | |||
| Current Asset | 88 M | |||
| Current Liabilities | 5 M | |||
| Net Asset | 58.7 M |
About ImpediMed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ImpediMed Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ImpediMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ImpediMed Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ImpediMed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ImpediMed's short interest history, or implied volatility extrapolated from ImpediMed options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImpediMed Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for ImpediMed Pink Sheet analysis
When running ImpediMed's price analysis, check to measure ImpediMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImpediMed is operating at the current time. Most of ImpediMed's value examination focuses on studying past and present price action to predict the probability of ImpediMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImpediMed's price. Additionally, you may evaluate how the addition of ImpediMed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |